Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Stock markets continue to rally globally
Wed, 14 Mar 09:30 am

Asian stock markets have opened the day on a firm note. Stock markets in Japan (up 2.0%), Hong Kong (up 1.3%) and Singapore (up 1.1%) are in the green. The Indian stock markets have opened the day on a firm note. Stocks in the capital goods and metals space are leading the gains.

The BSE-Sensex is trading up by 180 points (1%) while the NSE-Nifty is up by around 55 points (1%). Mid cap and small cap stocks are trading in the green, with the BSE Mid cap and BSE Small cap indices up by 0.6% and 0.5% respectively. The rupee is trading at Rs 49.91 to the US dollar.

Pharma Stocks have opened the day on a firm note with Ranbaxy Laboratories and Cipla in the green. Indian pharma major Ranbaxy Laboratories Ltd which has a strong presence in Africa has now opened a new manufacturing facility in Casablanca, Morocco. This move will help the company do business directly in various parts of North Africa. The market in Morocco market is estimated to be around US$ 1 bn. Ranbaxy has already completed a successful audit of the facility by the Moroccan health authorities. The company has obtained an authority to start production at its new facility. The company has now identified Morocco as the most important market in Africa. It has plans of supplying to other African nations from Morocco. In Africa, Ranbaxy also has facility in Nigeria and South Africa. The company also has a distribution network which covers 44 out of 54 African Nations.

Auto Stocks have opened the day on a firm note with Tata Motors (Telco) and Maruti Suzuki in the green. Tata Motors owned Jaguar Land Rover is planning to assemble Jaguar luxury cars in India after 3 years. The company management said that they are looking at it but as of now the volumes in India are very small. Therefore, it does not make sense to set up an assembly unit for it currently. At present the British company assembles sports utility vehicle brand Land Rover's Freelander at Tata Motors' Pune plant. The company did not spare any specific details about the timing and location of the assembling plant. During the first half of the year, the total sales of Jaguar and Land Rover was 891 units. This was quite higher when compared to the 242 sold in the previous year.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Stock markets continue to rally globally". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.